Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SIRT1 inhibitors(NAD-dependent deacetylase sirtuin 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14N2O |
InChIKeyXKEIBCWTOUEGSH-UHFFFAOYSA-N |
CAS Registry31785-60-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | KR | 01 Jan 2020 | |
Ovarian Cancer | Preclinical | KR | 01 Jan 2020 |